OsteoRemedies gets expanded indication for dual antibiotic bone cement

OsteoRemedies got new FDA clearances for its Spectrum GV dual antibiotic bone cement, according to an April 23 news release.

Advertisement

The Spectrum bone cement’s new indications cover the fixation of revision hip arthroplasty components. It was launched in 2018 for total joint replacement.

Spectrum has vancomycin and gentamicin, which has antibacterial properties. 

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Orthopedic

Advertisement

Comments are closed.